Such ethnical differences have been described for various relevant molecular cancer features, including HER2 amplification in breast cancer [50], TMPRSS2-ERG gene fusion in prostate cancer [51], and MET mutation in lung cancer [52]. This evidence concerns the gene ERBB2 and lung carcinoma.